A PATHOLOGICAL STUDY ON BORDERLINE OVARY TUMORS

被引:0
|
作者
Rehman, Toheed [1 ]
Hassan, Khalid [2 ]
Gul, Wahid [3 ]
机构
[1] Mardan Med Complex, Mardan, Pakistan
[2] BHU Hayaseri Dir Lower Temergara Maidan, Lahore, Pakistan
[3] Lady Reading Hosp, Peshawar, Pakistan
来源
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2019年 / 6卷 / 06期
关键词
Borderline Ovarian Tumors; Fertility Sparing Cancer; Fertility Preserving Surgery; Chemotherapy; Radiotherapy; CONSERVATIVE TREATMENT; OOPHORECTOMY; RECURRENCE; OUTCOMES; CANCER; IMPACT; WOMEN;
D O I
10.5281/zenodo.3258825
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: The aim of this study is to describe occurrence and treatment of BOTs (Borderline Ovarian Tumors) in under developing countries like Pakistan. Methodology: It is an observational study of patients suffering from borderline ovarian tumors, for the duration of 10 years from 2008 to 2018 at Lady Reading Hospital Peshawar. This research work includes observation of types, characteristics and cure of BOTs. We retrieved and classified the calculated data. Results: We identified 86 patients suffering from borderline ovarian tumors with an average age of thirty-five years. According to our research, 42 patients were suffering from serous borderline ovarian tumors, 43 patients were suffering from mucinous borderline ovarian tumors and one patient was suffering from mixed typed. We categorized patients by the usage of international federation of gynecology and obstetrics (FIGO) standards. The complete removal of tumor occurred in 70 patients. There were 43 patients, who experienced FPS (fertility preserving surgery). After the duration of 31.50 months, seventy-three patients were having no disease. There was reappearance of disease in thirteen patients. The factors responsible for recurrence of invasive tumors are; having age more than 40 years, partial surgery and current stage of disease. Conclusion: Although BOTs is less harmful disease, there is possibility of recurrence in patients having age more than 40 years, not-completed surgery or higher stage at the time of treatment. FSS is considerable, in case of young patients. To minimize the relapse of the disease removal of tumor and treatment for a long time is necessary.
引用
收藏
页码:13151 / 13156
页数:6
相关论文
共 50 条
  • [1] Borderline tumors of the ovary: A clinicopathological study
    Yasmeen, Samia
    Hannan, Abdul
    Sheikh, Fareeha
    Syed, Amir Ali
    Siddiqui, Neelam
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (02) : 369 - 373
  • [2] BORDERLINE TUMORS OF THE OVARY
    BARAKAT, RR
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1994, 21 (01) : 93 - 105
  • [3] BORDERLINE TUMORS OF THE OVARY
    SCULLY, RE
    BELL, DA
    RUTGERS, JL
    PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (04) : 555 - 555
  • [4] Borderline tumors of the ovary
    Uzan, Catherine
    Gouy, Sebastien
    Balleyguier, Corinne
    Zareski, Elise
    Lhomme, Catherine
    Pautier, Patricia
    Duvillard, Pierre
    Morice, Philippe
    IMAGERIE DE LA FEMME, 2009, 19 (01) : 37 - 40
  • [5] BORDERLINE TUMORS OF THE OVARY
    SCULLY, RE
    BELL, DA
    RUTGERS, JL
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1987, 6 (04) : 389 - 389
  • [6] Borderline tumors of the ovary
    Kommoss, F
    Richter, B
    Breitbach, GP
    GYNAKOLOGE, 2001, 34 (11): : 1003 - +
  • [7] Borderline malignant tumors of the ovary: Study of prognostic factors
    Chow, SN
    Chen, CD
    Chen, YP
    Hsieh, CY
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1996, 95 (11) : 851 - 856
  • [8] Serous borderline tumors of the ovary
    Machin, P
    de Nictolis, M
    Prat, J
    MODERN PATHOLOGY, 2001, 14 (01) : 140A - 140A
  • [9] Borderline epithelial tumors of the ovary
    Hart, WR
    MODERN PATHOLOGY, 2005, 18 : S33 - S50
  • [10] Serous borderline tumors of the ovary
    Prat, J
    UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 122 - 125